S&P 500

5.304,72

0,70%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Atherogenics (MM) (AGIX)
Atherogenics (MM) (AGIX) Notícias

AGIX

Atherogenics (AGIX)

Atherogenics (MM)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:AGIX

1 2 3 4 5 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
10/10/2008	18:23	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:AGIX	Atherogenics (MM)
10/10/2008	18:15	Marketwired	AtheroGenics Receives Delisting Notice From NASDAQ Global Market Due to Chapter 11 Filing	NASDAQ:AGIX	Atherogenics (MM)
10/10/2008	16:35	Edgar (US Regulatory)	Withdrawal of Registration Statement (RW)	NASDAQ:AGIX	Atherogenics (MM)
07/10/2008	09:20	Edgar (US Regulatory)	Atherogenics Inc - Current report filing (8-K)	NASDAQ:AGIX	Atherogenics (MM)
07/10/2008	07:51	Marketwired	AtheroGenics Files for Chapter 11 Bankruptcy	NASDAQ:AGIX	Atherogenics (MM)
10/09/2008	20:13	Marketwired	AtheroGenics Restructures Board of Directors	NASDAQ:AGIX	Atherogenics (MM)
02/09/2008	12:44	Marketwired	BellwetherReport.com Analyst Opinions on SCRX, AGIX, BUCY and ISIL	NASDAQ:AGIX	Atherogenics (MM)
02/09/2008	09:39	Marketwired	AtheroGenics Seeks to Realign Capital Structure	NASDAQ:AGIX	Atherogenics (MM)
25/08/2008	16:00	Edgar (US Regulatory)	Atherogenics Inc - Confidential Treatment Order (CT ORDER)	NASDAQ:AGIX	Atherogenics (MM)
20/08/2008	07:24	Edgar (US Regulatory)	Atherogenics Inc - Application for qualification of trust indentures (T-3)	NASDAQ:AGIX	Atherogenics (MM)
05/08/2008	08:00	Marketwired	AtheroGenics Reports Second Quarter 2008 Financial Results	NASDAQ:AGIX	Atherogenics (MM)
01/08/2008	11:20	PR Newswire (US)	BeaconEquity.com Issues Technical Trade Alerts on Market Movers: AGIX, APKT, BIOS, NOVA, CNXT, CHRD	NASDAQ:AGIX	Atherogenics (MM)
31/07/2008	12:27	Marketwired	BellwetherReport.com Analyst Report on HOLX, AKAM, SBUX and AGIX	NASDAQ:AGIX	Atherogenics (MM)
31/07/2008	08:00	Marketwired	AtheroGenics Reports Positive Results From ANDES Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes	NASDAQ:AGIX	Atherogenics (MM)
25/07/2008	08:15	Marketwired	AtheroGenics to Report Second Quarter 2008 Financial Results on August 5, 2008	NASDAQ:AGIX	Atherogenics (MM)
30/06/2008	10:21	Marketwired	AtheroGenics Receives Notice of Non-Compliance With Listing Requirement for the NASDAQ Global Market	NASDAQ:AGIX	Atherogenics (MM)
19/06/2008	10:20	PR Newswire (US)	BeaconEquity.com Issues TraderNotes on Stocks: TPIM, NSM, BRLC, AGIX, AROX, TLEO, HLYS, ABAT	NASDAQ:AGIX	Atherogenics (MM)
10/06/2008	10:17	Marketwired	AtheroGenics Reports Clinical Data on Novel Anti-Inflammatory Anti-Oxidant Agent, AGI-1067, at American Diabetes Association Ann	NASDAQ:AGIX	Atherogenics (MM)
04/06/2008	08:30	Marketwired	AtheroGenics Announces Five Abstracts Accepted for the American Diabetes Association's 68th Annual Scientific Sessions	NASDAQ:AGIX	Atherogenics (MM)
23/05/2008	16:38	Edgar (US Regulatory)	Atherogenics Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGIX	Atherogenics (MM)
22/05/2008	21:55	Marketwired	AtheroGenics' ARISE Trial Results Published in The Lancet	NASDAQ:AGIX	Atherogenics (MM)
09/05/2008	18:10	Edgar (US Regulatory)	Atherogenics Inc - Quarterly Report (10-Q)	NASDAQ:AGIX	Atherogenics (MM)
30/04/2008	15:51	Marketwired	/ CORRECTION - AtheroGenics to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference on May 2, 2008	NASDAQ:AGIX	Atherogenics (MM)
30/04/2008	11:57	Marketwired	AtheroGenics to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference on May 2, 2008	NASDAQ:AGIX	Atherogenics (MM)
24/04/2008	08:00	Marketwired	AtheroGenics Reports First Quarter 2008 Financial Results	NASDAQ:AGIX	Atherogenics (MM)
18/04/2008	10:33	Edgar (US Regulatory)	Atherogenics Inc - Proxy Statement (definitive) (DEF 14A)	NASDAQ:AGIX	Atherogenics (MM)
17/04/2008	10:18	Marketwired	AtheroGenics to Report First Quarter 2008 Financial Results on April 24, 2008	NASDAQ:AGIX	Atherogenics (MM)
14/04/2008	08:00	Marketwired	AtheroGenics Announces Encouraging Interim Results From Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes	NASDAQ:AGIX	Atherogenics (MM)
07/04/2008	17:38	Edgar (US Regulatory)	Atherogenics Inc - Amended Statement of Changes in Beneficial Ownership (4/A)	NASDAQ:AGIX	Atherogenics (MM)
11/03/2008	10:31	Marketwired	AtheroGenics to Present at Lehman Brothers Global Healthcare Conference March 18, 2008	NASDAQ:AGIX	Atherogenics (MM)